BBC icon

Virtus LifeSci Biotech Clinical Trials ETF

16 hedge funds and large institutions have $12.4M invested in Virtus LifeSci Biotech Clinical Trials ETF in 2019 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
16
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
1
$4.45M
2
$3.81M
3
$1.38M
4
$842K
5
$742K
6
$508K
7
$479K
8
$71K
9
$39K
10
$33K
11
$33K
12
$10K
13
$9K
14
$5K
15
$4.19K
16
$2K
17
18